MedTrace Logo

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal

NCT05169619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 842

Last updated 2025-03-06

No results posted yet for this study

Summary

This study aims to determine the prevalence of Asthma, Difficult-to-Treat and Severe Asthma in Portugal, and characterize patients to better understand their disease characteristics, treatment profile and health care resource use to improve clinical management of the disease.

Conditions

Sponsors & Collaborators

  • Faculdade de Medicina da Universidade do Porto - CINTESIS

    collaborator UNKNOWN

  • Universidade do Minho - ICVS

    collaborator UNKNOWN

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • João Fonseca, MD/PhD · cintesis

  • Jaime Correia de Sousa, MD/PhD · ICVS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2024-03-06
Completion
2024-03-06

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05169619 on ClinicalTrials.gov